sarcomatoid mesothelioma (Cancer)
Information
- Disease name
- sarcomatoid mesothelioma
- Disease ID
- DOID:4488
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT01064648 | Active, not recruiting | Phase 1/Phase 2 | Pemetrexed Disodium and Cisplatin With or Without Cediranib Maleate in Treating Patients With Malignant Pleural Mesothelioma | March 15, 2010 | March 7, 2025 |
| NCT02399371 | Active, not recruiting | Phase 2 | Pembrolizumab in Treating Patients With Malignant Mesothelioma | March 31, 2015 | March 20, 2026 |
| NCT01861301 | Terminated | Phase 2 | Tivantinib in Treating Patients With Previously Treated Malignant Mesothelioma | January 2013 | March 2015 |
- Disase is a (Disease Ontology)
- DOID:1790
- Cross Reference ID (Disease Ontology)
- NCI:C45655
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:54443001
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0334513
- Exact Synonym (Disease Ontology)
- malignant fibrous mesothelioma
- Exact Synonym (Disease Ontology)
- spindled mesothelioma